MMR Vaccination May Prevent COVID-19 in Children

The results of a new study published by the American Society for Microbiology on November 20, 2020, demonstrate that there is a significant inverse correlation between mumps titers from the measles-mumps-rubella (MMR) vaccine and COVID-19 severity.

Jeffrey E. Gold, president of World Organization, in Watkinsville, Georgia, stated in a press release: "This (study) may explain why children have a much lower COVID-19 case rate than adults, as well as a much lower death rate."

"The majority of children get their first MMR vaccination around 12 to 15 months of age."

Study co-author David J. Hurley, Ph.D., professor and molecular microbiologist at the University of Georgia, added: "The MMR II vaccine is considered a safe vaccine with very few side effects. If it has the ultimate benefit of preventing infection from COVID-19, preventing the spread of COVID-19, reducing the severity of it, or a combination of any or all of those, it is a very high reward, low-risk ratio intervention."